Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 4/2017

06-09-2016

The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome

Auteurs: Kyle W. Murdock, Xin Shelley Wang, Qiuling Shi, Charles S. Cleeland, Christopher P. Fagundes, Suzanne D. Vernon

Gepubliceerd in: Quality of Life Research | Uitgave 4/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Debilitating fatigue is a core symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, the utility of patient-reported symptom outcome measures of fatigue for ME/CFS patients is problematic due to ceiling effects and issues with reliability and validity. We sought to evaluate the performance of three patient-reported symptom measures in a sample of ME/CFS patients and matched controls.

Methods

Two hundred and forty ME/CFS patients and 88 age, sex, race, and zip code matched controls participated in the study. Participants completed the Multidimensional Fatigue Inventory-20, DePaul Symptom Questionnaire, and RAND SF-36.

Results

The general and physical fatigue subscales on Multidimensional Fatigue Inventory-20, as well as the role of physical health on the RAND SF-36, demonstrated questionable or unacceptable internal consistency and problematic ceiling effects. The DePaul Symptom Questionnaire demonstrated excellent internal reliability, and less than 5 % of participants were at the ceiling on each subscale. The post-exertional malaise subscale on the DePaul Symptom Questionnaire demonstrated excellent clinical utility as it was able to differentiate between ME/CFS patients and controls (OR 1.23, p < .001) and predicted ceiling effects on other patient-reported outcome subscales. A score of 20 on the post-exertional malaise subscale of the DePaul Symptom Questionnaire optimally differentiated between patients and controls.

Conclusions

Significant ceiling effects and concerns with reliability and validity were observed among Multidimensional Fatigue Inventory-20 and RAND SF-36 subscales for ME/CFS patients. The DePaul Symptom Questionnaire addresses a number of concerns typically identified when using patient-reported outcome measures with ME/CFS patients; however, an improved multidimensional patient-reported outcome tool for measuring ME/CFS-related symptoms is warranted.
vorige artikel Acceptance and patient functioning in chronic pain: the mediating role of physical activity
volgende artikel A community-based cross-sectional study of sleep quality in middle-aged and older adults
Literatuur
1.
2.
3.
Fukuda, K., et al. (1994). The chronic fatigue syndrome—A comprehensive approach to its definition and study. Annals of Internal Medicine, 121(12), 953–959.CrossRefPubMed
4.
Haney, E., et al. (2015). Diagnostic methods for myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Annals of Internal Medicine, 162(12), 834–840.CrossRefPubMed
5.
Institute of Medicine of the National Academies (2015). Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness-report guide for clinicians. Washington, DC: Institute of Medicine of the National Academies.
6.
Holmes, G. P., et al. (1988). Chronic fatigue syndrome: A working case definition. Annals of Internal Medicine, 108, 387–389.CrossRefPubMed
7.
Fukuda, K., et al. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine, 121, 953–959.CrossRefPubMed
8.
De Becker, P., McGregor, N., & De Meirleir, K. (2001). A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome. Journal of Internal Medicine, 250(3), 234–240.CrossRefPubMed
9.
Reeves, W. C., et al. (2003). Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Services Research, 3(1), 1–9.CrossRef
10.
Jason, L. A., et al. (2015). Test–retest reliability of the DePaul Symptom Questionnaire. Fatigue: Biomedicine, Health & Behavior, 3(1), 16–32.
11.
Carruthers, B. M., et al. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols (Canadian case definition). Journal of Chronic Fatigue Syndrome, 11(1), 7–115.CrossRef
12.
Haywood, K. L., Staniszewska, S., & Chapman, S. (2012). Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): A systematic review. Quality of Life Research, 21(1), 35–52.CrossRefPubMed
13.
Jason, L. A., et al. (2011). Fatigue scales and chronic fatigue syndrome: Issues of sensitivity and specificity. Disability Studies Quarterly, 31(1), 1375.CrossRefPubMedPubMedCentral
14.
Friedberg, F., et al. (2000). Symptom patterns in long-duration chronic fatigue syndrome. Journal of Psychosomatic Research, 48(1), 59–68.CrossRefPubMed
15.
Jason, L. A., Corradi, K. C., & Torresharding, S. (2007). Toward an empirical case definition of CFS. Jounral of Social Service Research, 34(2), 43–54.CrossRef
16.
Nisenbaum, R., et al. (1998). Factor analysis of unexplained severe fatigue and interrelated symptoms—Overlap with criteria for chronic fatigue syndrome. American Journal of Epidemiology, 148(1), 72–77.CrossRefPubMed
17.
Nisenbaum, R., et al. (2004). Factor analysis of symptoms among subjects with unexplained chronic fatigue—What can we learn about chronic fatigue syndrome? Journal of Psychosomatic Research, 56(2), 171–178.CrossRefPubMed
18.
Hickie, I. B., et al. (2001). Development of a simple screening tool for common mental disorders in general practice. The Medical Journal of Australia, 175, S10-7.PubMed
19.
Brown, A. A., & Jason, L. A. (2014). Validating a measure of myalgic encephalomyelitis/chronic fatigue syndrome symptomatology. Fatigue: Biomedicine, Health & Behavior, 2(3), 132–152.
20.
Jason, L. A., et al. (2015). Factor analysis of the DePaul Symptom Questionnaire: Identifying core domains. Journal of Neurology and Neurobiology, 1(4), 1–9.
21.
Whitehead, L. (2009). The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. Journal of Pain and Symptom Management, 37(1), 107–128.CrossRefPubMed
22.
Amtmann, D., et al. (2012). Comparison of the psychometric properties of two fatigue scales in multiple sclerosis. Rehabilitation Psychology, 57(2), 159–166.CrossRefPubMedPubMedCentral
23.
Elbers, R. G., et al. (2012). Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson’s disease. Parkinsonism & Related Disorders, 18(5), 532–536.CrossRef
24.
Ferentinos, P., et al. (2011). Psychometric evaluation of the Fatigue Severity Scale in patients with major depression. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 20(3), 457–465.CrossRef
25.
Stouten, B. (2005). Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Services Research, 5, 37.CrossRefPubMedPubMedCentral
26.
Knoop, H., et al. (2007). Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? Psychotherapy and Psychosomatics, 76(3), 171–176.CrossRefPubMed
27.
White, P. D., et al. (2013). Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychological Medicine, 43(10), 2227–2235.CrossRefPubMedPubMedCentral
28.
29.
Jason, L. A., et al. (2010). The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. American Journal of Biochemistry and Biotechnology, 6(2), 120–135.CrossRef
30.
Whiting, P., et al. (2001). Interventions for the treatment and management of chronic fatigue syndrome—A systematic review. Journal of the American Medical Association, 286(11), 1360–1368.CrossRefPubMed
31.
Irlbeck, D. M., Vernon, S., McCleary, K., Bateman, L., Klimas, N. G., Lapp, C. W., et al. (2014). No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukiemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank. BMC Research Notes, 4(7), 461.CrossRef
32.
Smets, E. M. A., et al. (1995). The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research, 39(3), 315–325.CrossRefPubMed
33.
Ware, J. E., & Sherbourne, C. D. (1992). The Mos 36-item short-form health survey (Sf-36): Conceptual-framework and item selection. Medical Care, 30(6), 473–483.CrossRefPubMed
34.
IBM (2012) IBM SPSS statistics for windows, version 21.0. Armonk, NY: IBM Corp.
35.
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297–334.CrossRef
36.
Cohen, J., et al. (2003). Alternative regression models: logistic, poisson regression, and the generalized linear model. In Applied multiple regression/correlation analysis for the behavioral sciences (3rd edn, pp. 479–535). New Jersey: Lawrence Erlbaum Associates in Mawah.
37.
Wang, X. S. (2013). Cancer-related fatigue. In A. M. Berger, J. L. Shuster, & J. H. von Roenn (Eds.), Principles and practice of palliative care and supportive oncology (pp. 84–95). Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins.
38.
Mokkink, L. B., et al. (2009). Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Quality of Life Research, 18(3), 313–333.CrossRefPubMed
39.
Kirkova, J., et al. (2006). Cancer symptom assessment instruments: A systematic review. Journal of Clinical Oncology, 24(9), 1459–1473.CrossRefPubMed
Metagegevens
Titel
The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome
Auteurs
Kyle W. Murdock
Xin Shelley Wang
Qiuling Shi
Charles S. Cleeland
Christopher P. Fagundes
Suzanne D. Vernon
Publicatiedatum
06-09-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1406-3

Andere artikelen Uitgave 4/2017

Quality of Life Research 4/2017 Naar de uitgave

OriginalPaper

Quality of life in people aged 65+ in Europe: associated factors and models of social welfare—analysis of data from the SHARE project (Wave 5)

OriginalPaper

Health-related quality of life in patients with serious non-specific symptoms undergoing evaluation for possible cancer and their experience during the process: a mixed methods study

OriginalPaper

Assessment of health-related quality of life, mental health status and psychological distress based on the type of pharmacotherapy used among patients with depression

OriginalPaper

Effects of horticulture therapy on nursing home older adults in southern Taiwan

OriginalPaper

Change in physical function among women as they age: findings from the Australian Longitudinal Study on Women’s Health

OriginalPaper

When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time